Back

Differences in the characteristics of patients with non-valvular atrial fibrillation who are newly prescribed apixaban, rivaroxaban, dabigatran and VKA in general practice in the UK

28 August 2016 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster session 3 - Anticoagulation in atrial fibrillation Atrial fibrillation (AF) ESC Premium Access ESC Congress 2016

About the speaker

Photo
Ms Gillian Stynes

Uxbridge (United Kingdom of Great Britain & Northern Ireland)

20 More presentations in this session

Presentation thumbnail
Doctor E. Ueno (Kahoku, JP)
Abstract
Presentation thumbnail
Ms G. Stynes (Uxbridge, GB)
Abstract Slides
Presentation thumbnail
Professor G. Lip (Liverpool, GB)
Abstract Slides
Presentation thumbnail
Doctor M. Rohla (Bern, CH)
Abstract
Presentation thumbnail
Doctor O. Erkuner (Heerlen, NL)
Abstract Slides

Access the full session

Session thumbnail
Poster session 3 - Anticoagulation in atrial fibrillation

The Event

Event poster

ESC Congress 2016

28 August 2016 14:00 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources